| NCT ID | NCT03471663 |
| Title | A First-in-Human Study of D-0502 Alone and in Combination With Palbociclib in Women With Advanced or Metastatic ER-Positive and HER2-Negative Breast Cancer |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | yes |
| Sponsors | InventisBio Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult senior |